CN Patent
CN107073082B — Xa因子解毒剂的冻干制剂
Assigned to Bortola Pharmaceutical Co ltd · Expires 2021-04-30 · 5y expired
What this patent protects
本公开涉及Xa因子(fXa)解毒剂的溶液和制备其冻干制剂的方法。适用于冻干的合适水性制剂可包括fXa解毒剂、增溶剂、稳定剂和结晶组分,其中所述制剂在冻干期间不崩塌。
USPTO Abstract
本公开涉及Xa因子(fXa)解毒剂的溶液和制备其冻干制剂的方法。适用于冻干的合适水性制剂可包括fXa解毒剂、增溶剂、稳定剂和结晶组分,其中所述制剂在冻干期间不崩塌。
Drugs covered by this patent
- Angiomax (BIVALIRUDIN) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.